Literature DB >> 12374230

Mutations of the APC gene in human sporadic colorectal cancers.

C De Filippo1, C Luceri, G Caderni, M Pacini, L Messerini, A Biggeri, E Mini, F Tonelli, F Cianchi, P Dolara.   

Abstract

BACKGROUND: Mutations of the APC gene are reported to occur frequently in sporadic colorectal adenomas and adenocarcinomas. We studied APC gene mutations in cases of human sporadic colorectal cancer in order to evaluate their correlation with pathologic characteristics and clinical prognosis.
METHODS: Most of the mutations of the APC gene (95%) are nonsense or frame shift mutations, encoding for truncated APC proteins. For this reason, mutation detection of the APC gene was performed using the in vitro synthesized protein (IVSP) assay, analysing the region between nucleotide 2058 and nucleotide 5079 of the gene, containing the mutation cluster region.
RESULTS: Out of 58 cases of colorectal cancer, 29 presented a mutated form of APC (mutation frequency 50%). We did not find a statistically significant correlation between APC gene mutation and age, sex, localization of the primary tumour, grading, Crohn-like lymphoid reaction or presence of residual adenoma. Tumours with low invasivity (Dukes' stages A and B) were less frequently mutated (12/27, 44.5%) than tumours of Dukes' stage C (15 out of 21, 71.4%), which developed macroscopically secondary metastasis with variable latency after surgery. Highly invasive tumours with synchronous metastases (Dukes' stage D) had, instead, a low frequency of APC mutations (20%, 2/10) (P = 0.02, compared with Dukes' stages A, B and C).
CONCLUSIONS: These data suggest that more aggressive Dukes' stage D tumours develop metastasis by means of an unknown mechanism, independent of APC mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374230     DOI: 10.1080/003655202320378248

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

Review 1.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

2.  The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.

Authors:  A Conlin; G Smith; F A Carey; C R Wolf; R J C Steele
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

Review 3.  Colorectal cancer: genetics of development and metastasis.

Authors:  Tetsuji Takayama; Koji Miyanishi; Tsuyoshi Hayashi; Yasushi Sato; Yoshiro Niitsu
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

4.  Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.

Authors:  Jy-Ming Chiang; Yah-Huei Wu Chou; Shih-Chieh Ma; Jim-Ray Chen
Journal:  Virchows Arch       Date:  2004-09-24       Impact factor: 4.064

5.  Somatic APC inactivation mechanisms in sporadic colorectal cancer cases in Hungary.

Authors:  Eniko Kámory; Judit Olasz; Orsolya Csuka
Journal:  Pathol Oncol Res       Date:  2008-03-28       Impact factor: 3.201

6.  Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression.

Authors:  Shakir M Saud; Weidong Li; Nicole L Morris; Matthias S Matter; Nancy H Colburn; Young S Kim; Matthew R Young
Journal:  Carcinogenesis       Date:  2014-10-03       Impact factor: 4.944

7.  Genetic alterations in colorectal cancer.

Authors:  Tannaz Armaghany; Jon D Wilson; Quyen Chu; Glenn Mills
Journal:  Gastrointest Cancer Res       Date:  2012-01

8.  Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.

Authors:  Margreet Lüchtenborg; Matty P Weijenberg; Petra A Wark; A Merdan Saritas; Guido M J M Roemen; Goos N P van Muijen; Adriaan P de Bruïne; Piet A van den Brandt; Anton F P M de Goeij
Journal:  BMC Cancer       Date:  2005-12-15       Impact factor: 4.430

9.  The genomics of colorectal cancer: state of the art.

Authors:  Andrew D Beggs; Shirley V Hodgson
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

10.  Genetic Biopsy for Prediction of Surveillance Intervals after Endoscopic Resection of Colonic Polyps: Results of the GENESIS Study.

Authors:  Andreas W Berger; Katja Raedler; Cord Langner; Leopold Ludwig; Nektarios Dikopoulos; Karl F Becker; Julia Slotta-Huspenina; Michael Quante; Daniel Schwerdel; Lukas Perkhofer; Alexander Kleger; Eugen Zizer; Franz Oswald; Thomas Seufferlein; Alexander Meining
Journal:  United European Gastroenterol J       Date:  2017-07-28       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.